will zolbetuximab impact the treatment landscape for gastric cancer?
Published 1 year ago • 926 plays • Length 2:56Download video MP4
Download video MP3
Similar videos
-
1:44
what role will zolbetuximab play in treating gastric cancer?
-
1:52
iilustro: zolbetuximab, mfolfox6, and nivolumab combinations for gastrointestinal cancer
-
2:17
claudin 18.2 and fgfr2b as novel targets in gastric cancer
-
1:07
claudin 18.2: a biomarker for gastric cancer
-
1:35
assessing the prevalence of cldn18.2 in gastric/gastroesophageal cancers
-
2:08
targeting cldn18.2 with zolbetuximab in gastric and gej cancer
-
3:34
flow spotlight: addressing nausea vomiting in gastric cancer treatment with 1l zolbetuximab
-
2:49
spotlight: zolbetuximab and m-folfox6 in cldn18.2 , her2- gej cancer
-
1:04
dr. ilson on the utility of zolbetuximab in claudin-positive gastric cancers
-
1:08
the role of neoadjuvant immunotherapy in msi-high gastric cancer
-
2:09
recent advances in gastrointestinal research: destiny-gastric01 and spotlight
-
0:51
claudin 18.2 as an emerging target in gastrointestinal cancers
-
3:03
targeted therapies for gastroesophageal adenocarcinoma
-
7:46
results from the phase 2 fast study of astellas’ investigational zolbetuximab
-
10:01
how astellas is forging a path in gastric cancer through its commitment to targeted research
-
1:05
limitations in immune checkpoint inhibitors in treating gastric cancer
-
1:03
novel treatments for gastric cancer
-
0:54
perioperative pembrolizumab for stomach cancer treatment
-
2:12
clinical trials investigating immunotherapy for gastric cancer